Catarina Ventura
Instituto Nacional de Saúde Dr. Ricardo Jorge
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Catarina Ventura.
American Journal of Medical Genetics Part A | 2013
Marisa Silva; Paula Caetano; Vanessa Olival; Cristina Alves; Laurentino Simão; Cristina Ferreira; Bárbara Marques; José Furtado; Catarina Ventura; Sérgio Soares; Hildeberto Correia
Chorionic villus sampling (CVS) is now well established as aninvasive test for prenatal diagnosis of chromosome abnormalitiesand some authors argue that this first-trimester procedurehas several advantages over mid-trimester amniocentesis in twinpregnancies [Brambati et al., 2001]. Since twin gestations seem tohave a higher risk of chromosome aberrations when compared tosingleton pregnancies, some centers now offer the possibility offirst-trimester prenatal diagnosis using CVS, including molecularrapidaneuploidy(MRA)testingbyQF-PCRormultiplexligation-dependent probe amplification (MLPA). CVS may provide thepossibility of an earlier result which may be crucial for patientreassurance and pregnancy management but has the disadvantageoftheoccasionalpresenceofplacentalmosaicism,inaround1–2%of cases, that can result from analyzing a tissue chromosomallydifferent from that of the fetus [Ledbetter et al., 1992; Farraet al., 2000]. This mosaicism may affect only the placenta—confined placental mosaicism (CPM)—or extend to the fetus—true fetal mosaicism (TFM)—in the same or in a different degreefrom the one found in the placenta [Kalousek et al., 1989; Gratietal.,2006].CPMoccursasoneofthreeforms:(i)theabnormalcelllineisconfinedtocytotrophoblast(typeI);(ii)oritonlyaffectsthestromalvillouscore(mesenchyme;typeII);(iii)oritinvolvesboth(typeIII)[Gratietal.,2006].Non-mosaicismforeitherdiploidyoraneuploidyispossibleinthefetus.Thekaryotypeofthecelllineagesisusuallyobtainedbydirectpreparations/short-term(cytotropho-blast) or long-term (mesenchyme) CVS cultures. MRA testing ispossible and is thought to test a mixture of DNAs from both thevillouscytotrophoblastandmesenchymalcore[Mannetal.,2007].However, this may yield discrepant results from the full chromo-someanalysisdependingonthemethod,thelevelofmosaicismandthetypeoftissueusedforanalysis.Thedisomy–trisomymosaicismmay have a mitotic (CPM types I and II) or a meiotic origin(CPM type III). The latter is associated with an increased risk ofpregnancy complications and fetal uniparental disomy (UPD)[Grati et al., 2006]. The detection of mosaicism for the commonautosomal trisomies in prenatal samples is relatively rare but hasbeen reported previously, as well as false-positive findings oftrisomy 18 mosaicism in CVS analysis [Schuring-Blomet al., 2002]. On the other hand trisomy 2 is one of the mostfrequently involved trisomies in pseudomosaicism both in amni-otic fluid (AF) and CVS cultures [Benn and Hsu, 2004; Sifakisetal.,2010].ToourknowledgethisisthefirstreportofadiscrepantCPMinadichorionic(DC)twinpairthatinvolvesatrisomy18anda trisomy 2.The patient was a 31-year-old, primigravid woman with DCtwins,conceivedafteraninvitrofertilization(IVF)procedureduetosequelaefrompreviouspelvicinflammatorydisease.Ultrasoundexamination (USE) at 11 weeks showed an umbilical hernia/smallomphalocele in twin B and a smaller crown-rump length (CRL;39 mm vs. 48 mm in twin A, 20th and 50th centile, respectively).First trimester aneuploidy screening on the basis of maternal ageand fetal nuchal translucency yielded normal results for twin A(1/2,499) and not calculable for twin B because the CRL was<45 mm. Since an ultrasound abnormality and early growth
Reunião Anual da SPH (Sociedade Portuguesa de Hematologia), 17-19 novembro 2016 | 2016
Maria do Céu Silva; Ana Paula Ambrósio; Neuza Silva; Catarina Ventura; Mónica Viegas; Paula Kjollerstrom; Raquel Maia; Hildeberto Correia
Boletim Epidemiológico Observações | 2016
Ana Paula Ambrósio; Maria do Céu Silva; José Furtado; Neuza Silva; Catarina Ventura; Mónica Viegas; Hildeberto Correia
10th European Cytogenetics Conference, 4-7 July 2015 | 2015
Silvia Serafim; Bárbara Marques; Brito Filomena; Sónia Pedro; Cristina Ferreira; Catarina Ventura; Isabel Gaspar; Hildeberto Correia
Reunião Anual da Sociedade Portuguesa de Hematologia, 20-22 novembro 2014 | 2014
Maria João Silva; Ana Paula Ambrósio; Neuza Silva; Catarina Ventura; José Furtado; Hildeberto Correia
European Human Genetics Conference-ESHG, May 31-June 3 2014 | 2014
Bárbara Marques; Cristina Ferreira; Catarina Ventura; Sónia Pedro; Diana Antunes; Luís Nunes; Hildeberto Correia
9th European Cytogenetics Conference,9th European Cytogenetics Conference, 29 June - 2 July 2013 | 2013
Bárbara Marques; Cristina Ferreira; Filomena Brito; Cristina Alves; Lucilia Carvalho; José Furtado; Catarina Ventura; Marisa Silva; Laurentino Simão; Joaquim Correia; Hildeberto Correia
17th International Conference on Prenatal Diagnosis and Therapy, 2–5 June 2013 | 2013
Marisa Silva; Maria Geraldes; Cristina Ferreira; Bárbara Marques; José Furtado; Catarina Ventura; Alvaro Cohen; Hildeberto Correia
Reunião Anual da Sociedade Portuguesa de Hematologia, 8-10 Novembro 2012 | 2012
Maria do Céu Silva; Ana Paula Ambrósio; Bárbara Marques; Catarina Ventura; Luís Vieira; Elizabeth Silva; Maria Céu Trindade; Hildeberto Correia
16ª Reunião Anual da Sociedade Portuguesa de Genética Humana, 22-24 Novembro 2012 | 2012
Laurentino Simão; Marisa Silva; Filomena Brito; Cristina Alves; Bárbara Marques; Cristina Ferreira; Paula Ambrósio; Maria do Céu Silva; Catarina Ventura; Guida Duarte; Paula Caetano; Joaquim Correia; A.A. Melo